Clinical Trial Update: Exparel and Education to Avoid Opioids After Carpal Tunnel Release [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating Exparel and patient education to reduce opioid use after carpal tunnel release is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carpal Tunnel Syndrome

Drugs mentioned

• Exparel (liposomal bupivacaine)

Snippet

Sponsor: Kettering Health Network | Conditions: Carpal Tunnel Syndrome | Phase 4 | Status: RECRUITING